Your browser doesn't support javascript.
loading
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs.
Zuur, Marlanka A; Pasipanodya, Jotam G; van Soolingen, Dick; van der Werf, Tjip S; Gumbo, Tawanda; Alffenaar, Jan-Willem C.
Afiliação
  • Zuur MA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Pasipanodya JG; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • van Soolingen D; National Institute for Public Health and the Environment, Bilthoven.
  • van der Werf TS; Department of Medical Microbiology, Radboud University Nijmegen Medical Centre.
  • Gumbo T; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Alffenaar JC; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
Clin Infect Dis ; 67(11): 1743-1749, 2018 11 13.
Article em En | MEDLINE | ID: mdl-29697766

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Isoniazida / Antituberculosos Tipo de estudo: Guideline / Health_economic_evaluation Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Isoniazida / Antituberculosos Tipo de estudo: Guideline / Health_economic_evaluation Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda